Pulmonary vascular resistance (PVR) is an important measurement for the diagnosis of patients with pulmonary hypertension (PH) but needs accurate determination of mean pulmonary artery pressure (PAMP). We aimed to test the accuracy of a Doppler-derived measurement of PVR, using the conventional invasive equation in patients with PH.
Introduction
Estimation of pulmonary artery pressure (PAP) is important in refining the diagnosis, optimizing follow-up after treatment and predicting prognosis in patients with pulmonary hypertension (PH). 1 Although non-invasive estimation of PAP by Doppler echocardiography is well established in clinical practice, 2 it does not account for variations in the flow. 3 A more accurate measurement of PH is thus needed. Pulmonary vascular resistance (PVR) reflects better the disease process; hence its measurement should account for most accurate disease assessment. Furthermore, PVR is known as a strong predictor for reduced exercise capacity in thromboembolic patients after thrombendarterectomy. 4 Right heart catheterization (RHC) is the gold standard investigation for determining pulmonary haemodynamics including vascular resistance, but its routine use is limited by its invasive nature and incurring cost.
Other non-invasive resting 5 -9 and exercise 10 methods have been proposed but with limited accuracy. 11 The aim of this study was therefore to test a new Doppler-derived method, based on conventional invasive measurement in estimating PVR in patients with PH.
Methods
We investigated 30 patients with PH of different aetiologies, undergoing diagnostic and follow-up RHC of a mean age 62 + 13 years and 21 were females. The aetiology of PH was classified according to guidelines 12 as idiopathic PAH (n ¼ 5), associated PAH (n ¼ 16), chronic thromboembolic type of PH (n ¼ 6), PH due to lung disease (n ¼ 2), and closed atrial septal defect (n ¼ 1). Patients were excluded from the study if they had signs of impaired left ventricular (LV) systolic function, as reduced ejection fraction (EF , 50%) or elevated mean pulmonary capillary wedge pressure (PCWP .15 mmHg on RHC).
Right heart catheterization
Venous access was obtained by inserting an introducer in a medial cubital vein or in the femoral vein. A retrograde catheterization was then performed using a Swan-Ganzw Standard Thermodilution Catheters (Edwards Lifesciences). Mean right atrial pressure (RAP), systolic and end-diastolic right ventricular pressures, pulmonary artery systolic, mean and diastolic pressures (PASP, PAMP and PADP, respectively), and PCWP were measured. Blood samples for estimation of oxygen saturation were drawn from the superior and inferior caval veins, as well as right atrium, and that from the pulmonary and femoral arteries were used for screening for intra-cardiac shunts. Cardiac output was determined by thermodilution. Pulmonary vascular resistance was calculated from the equation PAMP2 PCWP (trans-pulmonary gradient) divided by CO.
Echocardiographic examination
Echocardiographic examination was performed using a Vivid 7 system (GE Medical Systems, Horten, Norway) equipped with an adult 1. (ii) The ratio of transtricuspid peak pressure drop/RV outflow tract velocity time integral.
(iii) PASP/(HR × RVOT velocity time integral)
. 18 We also measured RV systolic deformation (strain) at the basal, midcavity and apical segments using STE. 9 
Statistical analysis
Normally distributed continuous data were expressed as mean + standard deviation. Relationships between variables were tested using Pearson's correlation. Partial correlations were made to control for age, sex and type of PH. The Bland -Altman test was used to evaluate the mean difference + 2SD, between echocardiography and RHC. The statistical software package (PASW Statistics version 18) was used for all calculations.
Results
Clinical characteristics are shown in Table 1 . The majority of patients were females and had PH, in most cases associated with connective tissue disease.
Relationships between invasive and new Doppler-derived measure of pulmonary vascular resistance
The new method (Lindqvist) was feasible in 90% of the cases and the results obtained correlated closely with PVR rhc (r ¼ 0.85, P , 0.001) with a regression equation of 0.95 × PVR echo 20.29 and the regression line close to identity ( Figure 1A) . The BlandAltman plot showed an excellent agreement between PVR echo and PVR rhc , with a bias of 20.66 + 2.1 ( Figure 1B) . The sensitivity and specificity of the method for identifying patients with PVR .3 WU were 100 and 63%, respectively, and negative and positive predictive values were 100 and 86%, respectively ( Table 2) . Using an estimated RAP of 7 mmHg resulted in a stronger correlation (r ¼ 0.87, P , 0.001) with a regression equation of 1 × PVR echo 2 0.08, ( Figure 1C ). The Bland-Altman plot showed an even tighter agreement between PVR echo and PVR rhc with a bias of 20.10 + 2.0 ( Figure 1D) . The sensitivity and specificity of the method for identifying patients with PVR .3 WU were 95 and 75%, respectively, and negative and positive predictive values were 90 and 86%, respectively ( Table 2 ). The correlation coefficient between CO from rhc and echo was r ¼ 0.76, P , 0.001.
Comparison between the newly proposed model and previous methods
Using the method by Selimovic et al., the estimated PVR was feasible in 76% and had a correlation with PVR rhc of r ¼ 0.77, P , 0.001. The linear regression equation was 0.74 × PVR echo + 0.29, and the regression line was close to identity only at low PVR but slightly overestimated PVR at higher levels ( Figure 2A) . The Bland-Altman analysis showed an acceptable agreement between PVR echo and PVR rhc , bias of 21.8 + 2.9 WU. The sensitivity and specificity of this method for identifying patients with elevated PVR, .3 WU, were 100 and 14%, respectively, with negative and positive predictive values of 100 and 66%, respectively ( Table 2 ). The method proposed by Abbas et al. was feasible in 83% and showed a good correlation with PVR rhc of r ¼ 0.78, P , 0.001. The regression equation was 22.5 × PVR echo + 0.62 with the regression line continuously overestimating PVR at all levels ( Figure 2B) . The Bland -Altman analysis showed an agreement between PVR echo and PVR rhc , bias ¼ 6.1 + 4.0 WU. The sensitivity and specificity using a cut-off value of . 0.175 for identifying patients with elevated PVR was 88 and 86%, respectively, and the negative and positive predictive values were 75 and 94%, respectively ( Table 2) .
The method by Haddad et al. was feasible in 80% and had a correlation of r ¼ 0.74, P , 0.001 in predicting PVR rhc . The regression equation was 88.5 × PVRecho + 0.98 with the regression line slightly overestimating PVR, at all levels ( Figure 2C) . The BlandAltman analysis showed an agreement between PVR echo and PVR rhc , bias ¼ 6.4 + 4.1 WU. The sensitivity and specificity using a cut-off value of ,0.04 for identifying patients with elevated PVR was 94 and 100%, respectively, and the negative and positive predictive values were 88 and 100%, respectively ( Table 2) .
Assessment of RV strain function using STE at mid-segment showed an acceptable feasibility of 77% but only modest correlation with PVR rhc (r ¼ 0.59, P , 0.01). The regression equation was PVR rhc ¼ RV strain × 0.20 + 2 ( Figure 2D) . The BlandAltman analysis showed a low agreement between PVR echo and PVR rhc , bias ¼ 21.0 + 7.9 WU. The sensitivity and specificity using a cut-off value of ,220% for identifying patients with elevated PVR was 88 and 63%, respectively, and the negative and positive predictive values were 71 and 82%, respectively ( Table 2) .
The correlations between Doppler echocardiography and RHC were not influenced by age, sex, or aetiology of PH.
Discussion Findings
This study shows that our Doppler-derived equation for estimating PVR proved very accurate in identifying patients with raised PVR. In the patient's group, as a whole, results of individual patients strongly correlated with the respective catheter-based measurements of PVR as well as CO. Finally, this correlation was not influenced by age, sex, or type of PH.
Data interpretation
Right heart catheterization has been the gold standard method for confirming the diagnosis of PH, providing accurate measurements of PAP and pulmonary vascular resistance. However, the method is limited to be used in the regular follow-up of patients because of its invasive nature and potential risks, despite being rare. Doppler echocardiography has become the investigation of choice for studying cardiac structure and function as well as estimating intra-cardiac and transvalvular pressures. Doppler echocardiography has particularly revolutionized our cardiology practice for assessing PAP non-invasively. Retrograde transtricuspid pressure drop using continuous wave Doppler is a solid routine estimate of peak PAP in most patients undergoing echocardiographic examination. It has, however, certain limitations particularly when RAP rises, right ventricular systolic function drops and tricuspid regurgitation becomes severe. In addition, the known limitation of pulmonary pressure measurements, which reflects the pulmonary circulation status, makes assessment of pulmonary vascular resistance a serious need for optimal patient management.
A number of Doppler echocardiographic measurements and equations for estimating PVR have been proposed and proved to have at least one of the four measures of accuracy: sensitivity, specificity, positive, or negative predictive values. However, direct comparison of our proposed equation showed high feasibility and significantly higher specificity and accuracy in identifying patients with raised pulmonary vascular resistance of .3 WU compared with previously published methods. Several factors can explain the higher accuracy of our method. We acquired our Doppler echocardiographic recordings at the same time of the direct invasive measurements, virtually simultaneously; therefore we limited potential variations in pressure and flow. We also did not factor for Doppler time measurements, which are generally dictated by the cycle length as well as the functional status of the right ventricular myocardium. Furthermore, our method used the same equation conventionally used during RHC to calculate PVR, thus comparing similar ingredients. In addition, we adhered to estimating PAMP using the same equation proposed by Aduen et al. and Chemla et al. 19, 20 , which has been well investigated. To our knowledge, this calculation of PAMP has not been previously used in the estimation of PVR. Finally, we did not include exact estimations of RAP or PCWP but instead a constant value of '10 or 7' for RAP and '10' for PCWP, having excluded patients with potential causes for raised atrial pressures. The reason behind this approach was the serious inaccuracies previously reported from using exact estimations of atrial pressures in patients with preserved LV ejection fraction. 21 -24 It seems, therefore, that we have succeeded in avoiding potential sources of under or overestimation of PVR using Doppler echocardiographic measurements. Furthermore, using 10 mmHg for RAP has been shown accurate in estimating pulmonary artery systolic pressures. 25 The correlation between our estimated values of the PVR and those obtained directly from RHC showed a value of r ¼ 0.85 and r ¼ 0.87 and gave a sensitivity and negative predictive values of 100% for both using 10 mmHg for RAP and 95 and 86%, respectively, using an RAP of 7 mmHg. This supports the proposed equation as a very viable non-invasive method for monitoring patients with pulmonary vascular disease.
Clinical application
We have proposed a simple Doppler-derived model for estimating PVR which is based on the invasive concept and proved to have excellent accuracy, high sensitivity and negative predictive value for monitoring patients with raised PVR. The sensitivity of this method in differentiating raised pulmonary pressures secondary to raised left atrial pressure remains to be determined.
Limitations
We intentionally excluded patients with poor LV function and those with raised left atrial pressure in order to obtain a pure form of raised PVR rather than values potentially clouded by leftside cardiac disease. Likewise, we excluded patients with severe tricuspid and aortic regurgitation as potential causes of inaccurate stroke volume measurement. Thus, our findings need to be re-tested in such groups of patients. None of our patients had more than moderate tricuspid regurgitation, making our equation potentially limited.
Conclusion
The proposed catheter based non-invasive formula for estimating PVR using Doppler-derived measurements strongly correlates with invasive gold standard measures and has high accuracy in identifying patients with raised pulmonary vascular resistance.
